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IntroductIon
Testicular carcinoid tumours are very rare and account for 
less than 1% of all testicular neoplasms.1  These tumours 
may be classified into three distinct groups, most commonly 
(1) primary testicular carcinoid, (2) carcinoid differentiation 
within a mature teratoma, and (3) metastases from an extra-
testicular source.  Testicular carcinoid tumours do not follow 
the age category of men affected most commonly by germ cell 
tumours (20-40 years), cases have been reported ranging in 
age from ten to eighty-three years.2  Presentation of carcinoid 
tumours may be with self-detected testicular mass or testicular 
ache as with common testicular tumours, or uncommonly with 
carcinoid syndrome. 
We report a case of primary carcinoid tumour of the testis 
without features of carcinoid syndrome.  
case report
A 29-year-old male presented to the outpatient clinic with 
a several week history of a painless right sided testicular 
swelling found on self-examination.  He had no recent history 
of trauma, urinary tract or sexually transmitted infections.   
On examination he had a hard mass in the upper aspect of 
his right testis which felt strongly suggestive of testicular 
tumour.  An ultrasound scan showed normal appearance of 
the left testis and a mixed echogenic mass occupying the 
majority of the superior aspect of the right testis.  The mass 
measured 3.5 x 2.3 cm and had increased vascularity (Figure 
1).  Tumour markers (beta human chorionic gonadotrophin, 
alfa-fetoprotein and lactate dehydrogenase) were normal and 
a pre-operative chest radiograph did not reveal any metastases.   
The patient underwent radical orchidectomy and insertion of 
testicular prosthesis soon after diagnosis.  
Histological analysis showed a well circumscribed tumour 
composed of monomorphic cells arranged in a nested 
trabecular pattern.  The tumour cells had granular chromatin 
and scarce mitotic figures.  Immunohistochemistry showed 
strong positive staining with chromogranin (Figure 2), 
synaptophysin (Figure 3), CD56 and PGP9.5.  These features 
were in keeping with a well differentiated carcinoid tumour 
with no teratomatous components or other germ cell elements.   
There was no lymphovascular invasion, the tumour was 
confined to the testis and had a low proliferation index.  
The patient subsequently had a staging computed tomogram 
(CT) of chest, abdomen and pelvis, which showed no 
significant para-aortic or iliac lymphadenopathy and no 
pulmonary abnormality.  Multiple mesenteric nodes were 
noted which were not said to be typical of spread of testicular 
tumour. 
The patient was referred to a specialist gastroenterologist for 
further investigation to rule out the possibility of testicular 
Fig 1. Ultrasound image of the right testis showing mixed 
echogenic mass in upper pole in keeping with testicular tumour
Fig 2. Monomorphic cells in nested trabecular pattern. Staining 
strongly positive with chromogranin© The Ulster Medical Society, 2011.
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metastasis from an extra-testicular primary carcinoid.  NM 
octreotide scan with SPECT showed two to three subtle foci 
of activity towards the dome of the right lobe of the liver in 
segment four and eight.  These were not definite for liver 
metastases, however, these could not be excluded. No lesions 
were found to be over expressing somatostatin receptors.   
Further evaluation with MRI confirmed that the areas of 
abnormality within the liver were consistent with simple cysts.     
dIscussIon
Testicular carcinoid tumours are a rare entity and are 
almost never suspected preoperatively. The majority are 
only diagnosed on histopathology as they do not become 
clinically apparent until there is metastatic spread or the 
presence of carcinoid syndrome.2  Carcinoid tumours 
arise from neuroendocrine cells, however, the presence of 
neuroendocrine cells has not been described in the testis, 
leaving the origin of primary testicular carcinoid debatable.3  
Several cellular origins of these tumours have been proposed.   
Mai et al found that the origin of testicular carcinoid tumours 
was located in the same progenitor cell from which Leydig 
cells derive.4  Merino et al support the possibility of a germ 
cell origin, finding intra-tubular germ cell neoplasia in the 
testicular tissue surrounding a pure carcinoid.3   Thus primary 
testicular carcinoid may be the remaining component of a 
burnt out teratoma or due to a one-sided development of 
teratoma.3,5 
Carcinoid syndrome is manifestation of carcinoid tumours and 
occurs as a result of the action of vasoactive tumour products.   
The syndrome is rare, occurring in approximately 10% of 
patients5 typically only once the tumour has metastasised to 
the liver or lungs.  Serotonin is the most common tumour 
product and when released into the systemic circulation it 
causes the symptoms of carcinoid syndrome.6 These include 
increased gastro-intestinal motility, bronchoconstriction, 
vascular constriction and dilatation.6 Serotonin is metabolised 
to 5-hydroxyindoleacetic acid (5-HIAA) which can be 
measured in the urine.  Any patient with vasoactive symptoms 
and a testicular lump should have 24 hour urinary 5-HIAA 
performed prior to surgery.      
Given that almost 10% of testicular carcinoids are metastases 
from another location,2 it is essential to thoroughly 
investigate these patients to find or exclude an extra-
testicular primary source.  A multimodal approach has been 
recommended.  Barium contrast studies and CT may detect 
mucosal thickening or luminal narrowing to suggest bowel 
involvement.   CT is also good for detecting mesenteric 
extension of the tumour and presence of liver metastases.7  
Somatostatin receptor scintigraphy using indium-111 labelled 
octreotide is now superior to CT in localisation of primary 
tumour site and has a sensitivity for detecting metastases 
of up to 96%.7 It has superseded meta-iodobenzylguanidine 
scanning which has a sensitivity of 50% for detecting 
metastases.7  These investigations also serve to detect 
synchronous tumours, as it is known that carcinoids have a 
high rate of second primary malignancy.6
Radical orchidectomy is curative for testicular confined 
carcinoid.5 The long-term prognosis of carcinoid tumours is 
dependent on size, association with teratoma and presence of 
metastases.  Zavala-Pompa et al showed that larger tumours 
(7.3 vs 2.9cm) and the presence of carcinoid syndrome 
predicted increased metastatic potential and hence poorer 
prognosis.8  The prognosis of carcinoid tumours arising within 
teratoma is better than pure testicular carcinoid.8  There have 
been several reports of carcinoid tumours causing delayed 
metastases, in one case 17 years after initial diagnosis, 
highlighting the need for long-term follow-up.9  Patients 
should undergo biochemical and radiological follow-up, 
however, the frequency and duration of follow-up remains 
open to debate.  Sutherland et al suggest that patients should 
undergo three monthly 5-HIAA measurements for the 
first year after diagnosis and annually thereafter.10  More 
recent guidelines suggest that urinary 5-HIAA levels do not 
accurately correlate with disease progression and metastases 
may occur in the absence of an elevated urinary 5-HIAA.   
Serum chromogranin A (a glycoprotein secreted by carcinoid 
tumours) has been reported to be a sensitive and specific 
marker which may correlate with relapse in gastrointestinal 
carcinoids.7  It may also be of use in the follow-up of testicular 
carcinoids, a fast rising level being associated with a poor 
prognosis.
In conclusion, testicular carcinoid tumours are very rare. It is 
imperative that once a testicular carcinoid tumour has been 
diagnosed; the patient undergoes thorough investigation to 
rule out an extra-testicular primary and metastases.  Long-
term biochemical and radiological follow-up is essential given 
potential for delayed metastases.
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